Founded in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz is a venture capital firm based in Menlo Park, California. The firm specializes in incubating and investing in startups across various stages, from seed to late-stage funding. It primarily focuses on sectors such as technology, including software, cloud computing, enterprise software, and consumer Internet. Additionally, it invests in emerging fields like artificial intelligence, fintech, and healthcare, specifically targeting companies at the intersection of technology and life sciences, such as digital therapeutics and computational medicine. Andreessen Horowitz is committed to fostering innovation and supporting companies that contribute to American dynamism, while strategically avoiding investments in areas like clean energy, transportation, and consumer retail.
Operating Partner and Head of Crypto Startup Accelerator
Jay Rughani
Investment Partner
Michael Sandwick
Partner, Consumer
Gil Shafir
Partner
Kristina Shen
General Partner
Jeffrey Silverstein
Partner
Arianna Simpson
General Partner
Sumeet Singh
Partner
Steven Sinofsky
Board Partner
Jack Soslow
Partner
Matt Spence
Partner
Nicole Stanners
Fundraise and IR Partner
Angela Strange
General Partner
Jeffrey Stump
Operating Partner
Jamie Sullivan
Partner
Robert H. Swan
Operating Partner
Satish Talluri
Partner
Kimberly Tan
Investment Partner
Carol Tang
Partner
Adela Tomsejova
Partner, Bio + Health
Dalton Turay
Partner
Gabriel Vasquez
Partner
Melissa Wasser
Partner of Fintech Capital Network
Tyler Wilson
Partner
Daisy Wolf
Investing Partner
Carra Wu
Partner, Crypto Investments
Kevin Wu
Partner
Guy Wuollet
Partner
Shangda Xu
Partner
Zeya Yang
Partner
JJ Yu
Partner, Capital Network
David Ulevitch
General Partner
Frank Chen
Partner
Jonathan Lai
Investment Partner
Matt Bornstein
Partner
Past deals in Health Insurance
Thatch
Series B in 2025
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Infinitus Systems
Series C in 2024
Infinitus Systems is an AI healthcare company focused on automating phone-based processes to enhance efficiency within the healthcare ecosystem. By streamlining tedious and time-consuming communication tasks, Infinitus aims to improve access to therapy, adherence, and affordability for patients. The company's innovative tool allows users to submit call requests easily, track updates, and receive notifications upon task completion. Infinitus Systems has raised $51.4 million in funding from prominent investors, including Kleiner Perkins, Coatue, and Google Ventures. Through its automation solutions, the company seeks to reduce the complexity and costs associated with back-office administration in the healthcare sector.
Counsel Health
Seed Round in 2024
Counsel Health helps patients to get access to medical advice virtually.
Thatch
Series A in 2024
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Headway
Series D in 2024
Headway is a mental healthcare system focused on providing affordable access to mental health services. It operates a virtual network of therapists who accept insurance and offer both video and in-person sessions that can be booked entirely online. This platform enables mental healthcare providers to expand their practices while allowing individuals to save on mental health sessions. By streamlining the process of accessing therapy, Headway aims to improve the overall accessibility and affordability of mental healthcare for users.
Q Bio
Venture Round in 2024
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.
Thyme Care
Series C in 2024
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Hippocratic AI
Series A in 2024
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Fortuna Health
Seed Round in 2023
Fortuna streamlines Medicaid navigation for consumers, covering eligibility, enrollment, and renewal processes seamlessly.
Waymark
Venture Round in 2023
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.
Headway
Series C in 2023
Headway is a mental healthcare system focused on providing affordable access to mental health services. It operates a virtual network of therapists who accept insurance and offer both video and in-person sessions that can be booked entirely online. This platform enables mental healthcare providers to expand their practices while allowing individuals to save on mental health sessions. By streamlining the process of accessing therapy, Headway aims to improve the overall accessibility and affordability of mental healthcare for users.
Hippocratic AI
Seed Round in 2023
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.
Zus Health
Series A in 2023
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.
Thatch
Seed Round in 2023
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Thatch
Pre Seed Round in 2023
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.
Pearl Health
Venture Round in 2022
Pearl Health is a technology and services company focused on enhancing primary care delivery and improving patient outcomes. Founded in 2020, it partners with thousands of primary care providers across 44 states to facilitate quality healthcare while rewarding providers for maintaining patient health. The company's platform offers a range of tools, including fixed per-member payments, clinical insights through analytics, and assistance with direct contracting programs. These resources enable physicians to concentrate on patient care while also reducing overall healthcare costs and optimizing performance within value-based care models for Traditional Medicare and Medicare Advantage. Pearl Health's team consists of experienced professionals from various fields, including medicine, public health, and technology, all dedicated to addressing significant challenges within the healthcare system.
Waymark
Series A in 2022
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.
Ribbon Health
Series B in 2021
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the quality and cost of care. The platform includes features such as provider directories, referral management, care navigation, and insurance enrollment. Ribbon Health serves various clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. The company was incorporated in 2016 and is headquartered in New York, New York. Originally named HealthWiz, Inc., it rebranded to Ribbon Health, Inc. in March 2018.
Thyme Care
Series A in 2021
Thyme Care is a healthcare company focused on providing comprehensive oncology care management services. It partners with health plans to deliver an integrated oncology solution that emphasizes whole-person care for cancer patients. By employing a tech-enabled platform, Thyme Care offers personalized support through physician-guided oncology nurses and resource specialists who educate and guide patients throughout their cancer journey. This model generates actionable insights that help healthcare providers identify at-risk patients earlier, facilitating timely access to quality resources and care. Thyme Care aims to enhance the cancer experience through early and ongoing intervention, ensuring that every cancer patient receives the individualized care they need.
Pearl Health
Series A in 2021
Pearl Health is a technology and services company focused on enhancing primary care delivery and improving patient outcomes. Founded in 2020, it partners with thousands of primary care providers across 44 states to facilitate quality healthcare while rewarding providers for maintaining patient health. The company's platform offers a range of tools, including fixed per-member payments, clinical insights through analytics, and assistance with direct contracting programs. These resources enable physicians to concentrate on patient care while also reducing overall healthcare costs and optimizing performance within value-based care models for Traditional Medicare and Medicare Advantage. Pearl Health's team consists of experienced professionals from various fields, including medicine, public health, and technology, all dedicated to addressing significant challenges within the healthcare system.
Bayesian Health
Venture Round in 2021
Bayesian Health Inc. is a digital health company based in New York, established in 2016. It specializes in an AI-driven platform that enhances patient monitoring by assessing illness severity and detecting changes in acuity. This technology integrates with hospital electronic medical records (EMR), allowing clinical staff and hospital leadership to access real-time data and insights. The platform provides actionable early detection alerts and supports decision-making in complex clinical environments, ultimately optimizing patient care throughout their hospital stay. By leveraging existing investments in EMR systems, Bayesian Health enables healthcare providers to make informed, data-driven decisions that improve safety and efficiency in patient management.
Zus Health
Series A in 2021
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.
Headway
Series B in 2021
Headway is a mental healthcare system focused on providing affordable access to mental health services. It operates a virtual network of therapists who accept insurance and offer both video and in-person sessions that can be booked entirely online. This platform enables mental healthcare providers to expand their practices while allowing individuals to save on mental health sessions. By streamlining the process of accessing therapy, Headway aims to improve the overall accessibility and affordability of mental healthcare for users.
Komodo Health
Series E in 2021
Komodo Health Inc. is a healthcare technology company that specializes in providing real-time healthcare intelligence and transparency through its innovative platform. Founded in 2014 and based in New York, with an additional office in San Francisco, the company offers a suite of software solutions, including its Healthcare Map, which tracks patient outcomes across the healthcare system. The platform utilizes advanced data science techniques and artificial intelligence to deliver insights that empower various stakeholders in the healthcare sector, including life science companies, payers, and providers. Key products such as Aperture, Pulse, and Serenity facilitate the analysis of complex healthcare connections, alert users to influence disease burden positively, and explore patient cohorts for deeper insights. By enabling a more cost-effective and value-driven healthcare system, Komodo Health aims to set a new standard for real-world data and analytics in the industry.
Honor
Series D in 2020
Honor is the largest senior care network and technology platform globally, dedicated to enhancing the quality of life for older adults and their families. Founded in 2014 in San Francisco by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg, the company aims to improve in-home care services for seniors. In 2021, Honor expanded its reach by acquiring Home Instead, which strengthened its network and introduced a relationship-based care model. The company combines workforce management and technology expertise with personalized care delivered through a network of third-party providers. This integrated approach allows older adults to receive reliable, transparent, and quality care, enabling them to live safely and comfortably in their own homes.
Ribbon Health
Series A in 2020
Ribbon Health, Inc. operates a software as a service (SaaS) platform that delivers essential data on healthcare providers, insurance plans, and the quality and cost of care. The platform includes features such as provider directories, referral management, care navigation, and insurance enrollment. Ribbon Health serves various clients, including health insurance companies, third-party administrators, clinics, hospitals, and digital health solutions. The company was incorporated in 2016 and is headquartered in New York, New York. Originally named HealthWiz, Inc., it rebranded to Ribbon Health, Inc. in March 2018.
Q Bio
Series B in 2020
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.
Komodo Health
Series C in 2020
Komodo Health Inc. is a healthcare technology company that specializes in providing real-time healthcare intelligence and transparency through its innovative platform. Founded in 2014 and based in New York, with an additional office in San Francisco, the company offers a suite of software solutions, including its Healthcare Map, which tracks patient outcomes across the healthcare system. The platform utilizes advanced data science techniques and artificial intelligence to deliver insights that empower various stakeholders in the healthcare sector, including life science companies, payers, and providers. Key products such as Aperture, Pulse, and Serenity facilitate the analysis of complex healthcare connections, alert users to influence disease burden positively, and explore patient cohorts for deeper insights. By enabling a more cost-effective and value-driven healthcare system, Komodo Health aims to set a new standard for real-world data and analytics in the industry.
Honor
Series C in 2018
Honor is the largest senior care network and technology platform globally, dedicated to enhancing the quality of life for older adults and their families. Founded in 2014 in San Francisco by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg, the company aims to improve in-home care services for seniors. In 2021, Honor expanded its reach by acquiring Home Instead, which strengthened its network and introduced a relationship-based care model. The company combines workforce management and technology expertise with personalized care delivered through a network of third-party providers. This integrated approach allows older adults to receive reliable, transparent, and quality care, enabling them to live safely and comfortably in their own homes.
Accolade
Series F in 2018
Accolade, Inc. is a technology-driven company that offers solutions to help individuals navigate the complexities of the healthcare system and workplace benefits in the United States. The company provides a cloud-based platform complemented by support from a team of health assistants and clinicians, including nurses and behavioral health specialists. Accolade's services are primarily aimed at employers who seek to enhance the healthcare experience for their employees and their families. By focusing on personalized health and benefits solutions, Accolade aims to improve healthcare outcomes while managing costs and increasing employee engagement. Founded in 2007, Accolade is headquartered in Plymouth Meeting, Pennsylvania.
Q Bio
Series A in 2018
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.
Accolade
Series E in 2016
Accolade, Inc. is a technology-driven company that offers solutions to help individuals navigate the complexities of the healthcare system and workplace benefits in the United States. The company provides a cloud-based platform complemented by support from a team of health assistants and clinicians, including nurses and behavioral health specialists. Accolade's services are primarily aimed at employers who seek to enhance the healthcare experience for their employees and their families. By focusing on personalized health and benefits solutions, Accolade aims to improve healthcare outcomes while managing costs and increasing employee engagement. Founded in 2007, Accolade is headquartered in Plymouth Meeting, Pennsylvania.
Q Bio
Seed Round in 2016
Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.
Oration
Series A in 2015
Oration is a provider of a prescription management platform aimed at addressing inefficiencies in the American healthcare system. The company offers predictive analytics tools that enhance the prescription purchasing experience, allowing consumers to make informed decisions based on cost and personal preferences. In the past year, Oration has analyzed over one billion dollars in healthcare transactions, partnering with some of the largest companies in the industry. By focusing on meaningful and complex problems, Oration seeks to empower consumers to save money that would otherwise be lost in the healthcare system, ultimately striving to create a more effective and transparent healthcare purchasing process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.